Our advice for clinicians on the coronavirus is here.
If you are a member of the public looking for information and advice about coronavirus (COVID-19), including information about the COVID-19 vaccine, go to the NHS website. You can also find guidance and support on the GOV.UK website.
NHS chief Simon Stevens will today announce that NHS England has struck deals to make innovative treatments for Multiple Sclerosis and breast cancer routinely available on the NHS. From tomorrow (10 November) hundreds of patients with Multiple Sclerosis are set to benefit from a new treatment option, Mavenclad, following a deal with drug company Merck. […]
NHS England, Public Health England, the Department of Health and NHS Improvement have today unveiled measures to boost the uptake of flu vaccinations along with package of new contingency actions to respond to pressures on frontline services this winter. Intensified preparations include: Providing free flu vaccines for hundreds of thousands of care home staff at […]
NHS England has today (Thursday 3 August) announced the start of a pioneering implementation trial to provide HIV prevention drugs to people at high risk of HIV infection. From September, pre-exposure prophylaxis (PrEP) will now be provided by the NHS through the initial three year trial to an estimated 10,000 people, in what will be […]
NHS England launches action plan to drive out wasteful and ineffective drug prescriptions, saving NHS over £190 million a year
NHS England has today published detailed plans – drawn up with family doctors and pharmacists – to cut out prescriptions for ineffective, over-priced and low value treatments. Helping to trim hundreds of millions from the nation’s rapidly growing drugs bill will create headroom to reinvest all savings in newer and more effective NHS medicines and […]
NHS patients with rare bone disease to benefit from potentially life-transforming drug due to “first of a kind” agreement between NHS England and the manufacturer
Children and adults with a rare inherited bone disease will be able to access a potentially life-enhancing drug, thanks to an innovative deal between NHS England, NICE and manufacturer Alexion. Hypophosphatasia (HPP) is a rare inherited bone condition that can appear any time from before birth to adulthood. In babies it is often fatal, and […]
An ongoing fight to raise awareness of over-medication of people with learning disabilities has been welcomed by the country’s top nurse. As it reached its first anniversary today Professor Jane Cummings spoke out in support of stop the over-medication of people with a learning disability or autism (STOMP) – a major initiative aimed at curbing […]
NHS England will be leading a review of low value prescription items from April 2017 and introducing new guidance for Clinical Commissioning Groups (CCGs), with a view to substantially saving NHS expenditure in this area. It follows extensive work by NHS Clinical Commissioners which identified significant areas where potential savings can be made, up to […]
NHS England has today (05 October 2016) launched a 30 day public consultation on a clinical commissioning policy proposition for commissioning medicines in children. There has already been extensive engagement on this national policy, it has been developed with the support and input of lead clinicians and patient and public representatives. This approach has helped […]
Action to prevent a future health crisis caused by antimicrobial resistance has seen the number of antibiotics prescribed in primary care fall substantially last year. The progress follows the introduction of financial incentives in April 2015 by NHS England working with Public Health England (PHE). Between April and December 2015, two million fewer prescriptions were […]
Work to date Over the last year, doctors, patient groups, Public Health England (PHE), NHS England and the Department of Health (DH) have worked together to investigate the role that Pre Exposure Prophylaxis (PrEP) could play in preventing HIV in those at the highest risk PrEP is a new way of using anti-retroviral drugs (ARVs) […]